Advertisement

 

 

Martinello et al.,HCV reinfection incidence among individuals treated for recent infection.

Martinello et al.,HCV reinfection incidence among individuals treated for recent infection.
Author Information (click to view)

Ingiliz P,


Ingiliz P, (click to view)

Ingiliz P,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Journal of viral hepatitis 2017 02 07() doi 10.1111/jvh.12686

Abstract

The development of all-oral direct-acting antiviral agents (DAA) has changed the management of patients infected with the hepatitis C virus (HCV). As these new treatments are safe and highly effective, most affected patients may have a chance for HCV cure, at least in those parts of the world where the costly drugs available. In industrialized countries, HCV infection has a comparatively low prevalence in the general population(1) . A higher prevalence and new infections are mainly seen in two specific subgroups: people who inject drugs (PWID) and HIV-positive men who have sex with men (MSM). This article is protected by copyright. All rights reserved.

Submit a Comment

Your email address will not be published. Required fields are marked *

20 + 12 =

[ HIDE/SHOW ]